Nav: Home

UF Health diabetes researchers discover way to expand potent regulatory cells

March 22, 2017

GAINESVILLE, Fla. -- For parents, storing their newborn baby's umbilical cord blood is a way to preserve potentially lifesaving cells. Now, a group of University of Florida Health researchers has found a way to expand and preserve certain cord-blood cells as a potential treatment for Type 1 diabetes.

The findings involve thymic regulatory T cells, a type of white blood cell that modulates the immune system and prevents autoimmune diseases such as Type 1 diabetes. The finding -- showing that so-called Tregs can be frozen at birth and later multiplied in a laboratory -- has important implications for Type 1 diabetes patients, researchers said. Harvesting Tregs from umbilical cord blood is safer, more efficient and potentially more effective than taking the cells from blood that circulates through the body, researchers said. These cells existed before the disease was triggered and would not be skewed by its chronic autoimmune attack.

Infusing patients with a large quantity of Tregs is one strategy already being used in clinical trials to stop Type 1 diabetes by preventing further destruction of insulin-producing beta cells in the pancreas. These trials have shown that adult blood Tregs are safe but not effective at reversing the disease.

Having a large, pure population of naïve Tregs that can be preserved and later multiplied in the laboratory is a crucial step toward the ultimate goal of stopping Type 1 diabetes in its early stages, said Todd M. Brusko, Ph.D., an associate professor in the UF College of Medicine's department of pathology, immunology and laboratory medicine. The findings were published recently in the journal Molecular Therapy.

"This is a really an important step in having the potential for safely treating patients with their own cells," Brusko said.

Establishing that Tregs from umbilical cord blood can be preserved at ultra-low temperatures and later propagated is significant because it gives patients the potential benefit of using their own cells if Type 1 diabetes arises in the future, said Michael J. Haller, M.D., a co-author of the study and a professor and chief of pediatric endocrinology in the UF College of Medicine.

During the study, the researchers started with 250,000 to 500,000 Tregs harvested from umbilical cord blood using a device called a fluorescent-activated cell sorter. Using microbeads that activate the cells and provide growth signals, the researchers successfully expanded the number of Tregs to a median yield of 1.26 billion cells. The researchers don't yet know exactly how many Tregs are needed to be effective in humans, but they said their results suggest that cryogenically preserved Tregs should be further tested as a potential treatment for Type 1 diabetes and other inflammatory and autoimmune diseases.

While using Tregs isn't a cure for Type 1 diabetes, Haller said it has the potential to prevent the disease or be effective in its early stages.

"People who develop Type 1 diabetes may have an imbalance in the number or function of certain immune cells. We now have the potential to repair that imbalance by replacing the defective cells. We can take the cells we want from the patient's cord blood, make more of them in the lab and give them back to the patient with a single infusion," he said.

Banking umbilical cord blood is a hedge against future medical problems, but it's not inexpensive. Storing cord blood in a private bank can cost $1,500 to $2,000 initially, plus several hundred dollars in annual fees. Haller said parents who can't afford to store umbilical cord blood should consider donating it to a public bank rather than letting the cells be discarded. Public banks provide cells to children and adults with cancers and other diagnoses which can sometimes be cured with cord blood transplantation.

Next, the research team will work on a small pilot study that will compare the Tregs derived from umbilical cord blood with Tregs that are harvested from blood that flows through the body. One of the questions researchers hope to answer is how well the two different cell therapies preserve insulin-producing beta cells in the pancreas. That trial should start in 2018.
-end-
In the present research, Brusko credited his laboratory manager, Howard Seay, M.Sc., with developing the procedures that allowed the Treg populations to be expanded over a 16-day period. The studies were done in collaboration with Jeffrey Bluestone, Ph.D., a professor at the University of California, San Francisco School of Medicine.

The research was funded by grants from umbilical cord blood banks Viacord and CBR Systems; the Juvenile Diabetes Research Foundation; the Howard P. and Mary Needles McJunkin Family Foundation and the National Institutes of Health.

University of Florida

Related Diabetes Articles:

The role of vitamin A in diabetes
There has been no known link between diabetes and vitamin A -- until now.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
Type 2 diabetes and obesity -- what do we really know?
Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
New cause of diabetes
Although insulin-producing cells are found in the endocrine tissue of the pancreas, a new mouse study suggests that abnormalities in the exocrine tissue could cause cell non-autonomous effects that promotes diabetes-like symptoms.
The Lancet Diabetes & Endocrinology: Reducing sugar content in sugar-sweetened drinks by 40 percent over 5 years could prevent 1.5 million cases of overweight and obesity in the UK and 300,000 cases of diabetes
A new study published in The Lancet Diabetes & Endocrinology journal suggests that reducing sugar content in sugar sweetened drinks (including fruit juices) in the UK by 40 percent over five years, without replacing them with any artificial sweeteners, could prevent 500,000 cases of overweight and 1 million cases of obesity, in turn preventing around 300,000 cases of type 2 diabetes, over two decades.
Breastfeeding lowers risk of type 2 diabetes following gestational diabetes
Women with gestational diabetes who consistently and continuously breastfeed from the time of giving birth are half as likely to develop type 2 diabetes within two years after delivery, according to a study from Kaiser Permanente published today in Annals of Internal Medicine.

Related Diabetes Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...